Courtney Minor, MD
Sleep Medicine · Louisville, KYNPI 1841640331
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,106 of the $1,259 with a category attached, or 87.8%. 9 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 33.6% of the total. 2025 is the largest year on record at $411, more than ten times the $18 reported in 2019. That places this record below the midpoint for sleep medicine clinicians in KY, where the typical reported total is $1,510.
Across 56 payments — averaging $22.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$423
- Harmony Biosciences LLC$288
- Axsome Therapeutics, Inc.$223
- Idorsia Pharmaceuticals US Inc$155
- Lilly USA, LLC$66
- Avadel CNS Pharmaceuticals, LLC$47
- plus $57 from 3 others
What the payments were for
- Food & beverage$1,10688%
- Education$15312%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 22 | $423 |
| Harmony Biosciences LLC | 9 | $288 |
| Axsome Therapeutics, Inc. | 11 | $223 |
| Idorsia Pharmaceuticals US Inc | 6 | $155 |
| Lilly USA, LLC | 4 | $66 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $47 |
| CSL Behring | 1 | $22 |
| Merck | 1 | $20 |
| Fisher & Paykel Healthcare Inc | 1 | $15 |
How this compares
$1,259 in reported general payments places this provider in the 35th percentile of 28 sleep medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Temazepam | 27 | $800 |
| Modafinil | 15 | $591 |
| Trazodone Hcl | 68 | $387 |
| Armodafinil | 11 | $379 |
| Gabapentin | 50 | $367 |
| Zolpidem Tartrate ErZolpidem Tartrate | 23 | $355 |
| Zolpidem Tartrate | 90 | $306 |
| Ropinirole Hcl | 27 | $251 |
| Eszopiclone | 14 | $169 |
| Mirtazapine | 15 | $98 |
| Clonazepam | 12 | $85 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Louisville
- Kevin TriceLouisville$220K
- William LacyLouisville$6K
- Robert KarmanLouisville$3K
- Egambaram SenthilvelLouisville$2K
- Juhee MianLouisville$2K
- Nicole ToddLouisville$2K
- Sarika ChandiramaniLouisville$2K
- Ammar AlmasalkhiLouisville$2K
- Warren ShaikunLouisville$1K
- Rajanna RamaswamyLouisville$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.